Skip to Main Content

Paper Details

Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen.
2
2023
HLA-A*03:01, HLA-presented (pHLA) peptides, KRAS G12V neoantigen, KRAS peptide, MANA, TCR mimic, TCRm, cancer, pHLA, wild-type G12 peptide
Author NameAffiliation
Chetan BettegowdaSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Chetan BettegowdaJohns Hopkins University School of Medicine
Chetan BettegowdaJohns Hopkins University School of Medicine
Chetan BettegowdaSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Nickolas PapadopoulosSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Nickolas PapadopoulosJohns Hopkins University School of Medicine
Nickolas PapadopoulosJohns Hopkins University School of Medicine
Nickolas PapadopoulosSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Kenneth W KinzlerBloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center
Kenneth W KinzlerJohns Hopkins University School of Medicine
Kenneth W KinzlerSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Kenneth W KinzlerSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Bert VogelsteinBloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center
Bert VogelsteinSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Bert VogelsteinSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Bert VogelsteinJohns Hopkins University School of Medicine
Bert VogelsteinJohns Hopkins University School of Medicine
Bert VogelsteinHoward Hughes Medical Institute
  • 1 - 18

Datasets